Research Peptides in Las Cruces, NM

Shipping research peptides to Las Cruces

Every Las Cruces order ships from Peptides Factory Direct as a stable lyophilized powder, packed for safe domestic transit to Las Cruces and the wider New Mexico research community. Lots are third-party tested to a 99%+ purity target, with identity confirmed by mass spectrometry and purity quantified by HPLC, and a Certificate of Analysis is available on request to support Las Cruces research records.

Research peptide categories shipped to Las Cruces

Las Cruces researchers can order across all seven research categories in the catalog. The table below maps each category to what it is studied for and example compounds.

Research peptides Las Cruces researchers request most

These are among the most-studied compounds shipped to Las Cruces and the surrounding New Mexico research community. Every profile is grounded in the research literature and provided strictly for laboratory context; nothing here is a human-use claim.

Hexarelin (potent GHRP) research

Hexarelin is a synthetic hexapeptide and one of the most potent growth-hormone-releasing peptides studied in research, with reported activity beyond GH release including cardiovascular-tissue signaling.

Research mechanism. Hexarelin strongly activates the GH-secretagogue receptor. Research notes desensitization with continuous exposure and increases in prolactin and cortisol, so cycled study designs are common.

Potent GH-release research. Studied where maximal GH-pulse stimulation is the variable.

Cardiac-tissue research. Examined for reported GH-independent cardiovascular signaling.

Cycled GHRP designs. Used in research that models receptor desensitization.

How it compares. Hexarelin is the most potent GHRP studied here but with the most off-target signaling and desensitization, contrasting with the gentler Ipamorelin.

Research pairings. Hexarelin is studied in cycled designs and monitored for prolactin/cortisol; it is rarely combined continuously with other GHRPs.

Reference research values. Research references commonly cite 100-200 mcg two to three times daily across 4-8 week cycles. Reference values only.

Full Hexarelin research profile → · Growth Hormone & Muscle peptides

N-Acetyl Semax Amidate (potent Semax analog) research

N-Acetyl Semax Amidate is a modified version of Semax with acetylation and amidation that the literature associates with greater potency and a longer active window in cognitive-research models.

Research mechanism. Like Semax, it is studied for BDNF and nerve-growth-factor signaling and monoamine modulation, with the modifications extending stability and duration in models.

Advanced cognitive research. Studied for focus, learning, and mental-clarity endpoints with a longer duration.

Neuroprotection research. Examined in neural-stress and recovery models.

BDNF-signaling research. A more stable model compound for neurotrophic studies.

How it compares. It is studied as more potent and longer-lasting than standard Semax, suited to demanding cognitive-research models.

Research pairings. Studied alongside Selank in cognitive-research designs.

Reference research values. Research references commonly cite 300-600 mcg daily across 2-4 week cycles. Reference values only.

Full N-Acetyl Semax Amidate research profile → · Cognitive & Neurological peptides

Vesugen (KED Vascular Bioregulator) research

Vesugen is a short vascular peptide bioregulator (a tripeptide, KED) from the Khavinson family, studied for endothelial and vessel-wall support signaling in research models. It is the vascular-tissue member of the short-peptide bioregulator group.

Research mechanism. Vesugen research focuses on vascular and endothelial tissue bioregulation - the concept that a tissue-specific short peptide can support normal endothelial function and vessel-wall protein synthesis - within cardiovascular-tissue research models.

Vascular / endothelial research. Studied for endothelial-function and vessel-support endpoints in models.

Cardiovascular-tissue research. Examined in bioregulator research focused on vascular tissue normalization.

Longevity bioregulator research. Investigated within the broader Khavinson bioregulator framework.

How it compares. Vesugen is the vascular/endothelial bioregulator, distinct from the organ bioregulator Ovagen and the neuro bioregulator Pinealon.

Research pairings. Studied alongside other Khavinson bioregulators (Epithalon, Ovagen, Pinealon) in tissue-support research designs.

Reference research values. Research references commonly cite 2-5 mg daily in short-course bioregulator study cycles. Reference values only - not for human or animal use.

Full Vesugen research profile → · Specialty peptides

KPV (Lysine-Proline-Valine) research

KPV is the C-terminal tripeptide (lysine-proline-valine) of the alpha-melanocyte-stimulating hormone. In research it is studied because it retains anti-inflammatory activity associated with the parent hormone without the pigmentation effects, making it a clean model compound for inflammation studies.

Research mechanism. KPV research focuses on its reported ability to enter cells and modulate inflammatory transcription pathways (such as NF-kB signaling), reducing pro-inflammatory cytokine output in models of gut and tissue inflammation.

Gut inflammation models. KPV is studied in models relevant to inflammatory bowel research (such as colitis and Crohn-type models) where epithelial inflammation is the variable.

General anti-inflammatory research. It is used as a model peptide for systemic and tissue inflammation studies with minimal off-target signaling.

Immune-modulation research. Its melanocortin lineage makes it relevant to immune-signaling investigations.

How it compares. Unlike BPC-157 and TB-500, which are studied for structural tissue repair, KPV is studied specifically for inflammatory signaling, making it complementary rather than competitive.

Research pairings. In healing research KPV is sometimes studied alongside BPC-157 for combined repair-and-inflammation models.

Reference research values. Research references commonly cite 500-1,000 mcg daily across a 4-12 week study window. Reference values only - not dosing for any subject.

Full KPV research profile → · Healing & Recovery peptides

Selank (anxiolytic nootropic) research

Selank is a synthetic heptapeptide derived from the immunomodulatory peptide tuftsin, developed in Russia. It is studied for anxiolytic (anti-anxiety) and cognitive endpoints without the sedation associated with classic anxiolytics.

Research mechanism. Selank research focuses on modulation of GABAergic and monoamine signaling and on brain-derived neurotrophic factor (BDNF) expression, with interest in anxiety and focus endpoints.

Anxiolytic research. Studied for anxiety endpoints without sedation in models.

Cognitive / focus research. Examined for attention and mental-clarity variables.

Neuroprotection and immune research. Its tuftsin lineage links it to immune-signaling studies.

How it compares. Selank is studied for anxiety endpoints where Semax is studied more for focus and BDNF; the two are complementary in cognitive research.

Research pairings. Selank + Semax is a common cognitive-research pairing (anxiety plus focus endpoints).

Reference research values. Research references commonly cite 250-500 mcg daily across 2-4 week cycles. Reference values only.

Full Selank research profile → · Cognitive & Neurological peptides

PT-141 (Bremelanotide) research

PT-141 (Bremelanotide) is a synthetic melanocortin-receptor agonist derived from Melanotan II. It is studied for sexual-function endpoints through a central-nervous-system mechanism rather than a vascular one.

Research mechanism. PT-141 research focuses on activation of melanocortin receptors (notably MC4R) in the central nervous system, which is the distinguishing feature versus vascular mechanisms studied for other compounds.

Libido / sexual-function research. Studied for arousal endpoints in both male and female models via CNS signaling.

Melanocortin-pathway research. A model compound for MC4R signaling studies.

Centrally-mediated research. Used where a central rather than vascular mechanism is the variable.

How it compares. Unlike vascular-pathway compounds, PT-141 acts centrally; unlike Melanotan I/II it is studied primarily for sexual-function rather than tanning endpoints.

Research pairings. Generally studied as a standalone melanocortin agonist.

Reference research values. Research references commonly cite 1-2 mg administered 45-90 minutes before the modeled endpoint, used as-needed rather than daily. Reference values only.

Full PT-141 research profile → · Sexual Health & Tanning peptides

GHK-Cu (Copper Peptide) research

GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine bound to copper). It is one of the most studied peptides in regenerative and dermatological research because of its role in copper transport and remodeling of the extracellular matrix.

Research mechanism. Research associates GHK-Cu with stimulation of collagen and elastin synthesis, antioxidant and anti-inflammatory signaling, and modulation of genes involved in tissue remodeling. The injectable form is studied separately from topical cosmetic applications.

Skin and tissue regeneration research. GHK-Cu is studied for wound-model healing, extracellular-matrix remodeling, and collagen synthesis.

Hair-follicle research. It appears frequently in hair-growth and follicle-signaling research models.

Anti-inflammatory and antioxidant studies. Its copper-transport role is studied for redox and inflammation endpoints.

How it compares. GHK-Cu targets skin, hair, and matrix research where BPC-157 and TB-500 target connective and muscle tissue, so it covers a distinct research niche.

Research pairings. In regenerative research GHK-Cu is sometimes paired with BPC-157 or TB-500 to model both structural and dermal repair.

Reference research values. Research references commonly cite 1-2 mg administered 3-5 times per week. Reference values only.

Full GHK-Cu research profile → · Healing & Recovery peptides

Pinealon (EDR Tripeptide) research

Pinealon is a short synthetic peptide bioregulator (a tripeptide) from the Khavinson family of peptide bioregulators. It is studied for neuroprotective, pineal/circadian, and cognitive-support concepts in research models, where short peptides are investigated for tissue-specific gene-regulatory activity.

Research mechanism. Pinealon research centers on peptide bioregulation in neural tissue - the idea that short peptides can influence gene expression and protein synthesis in a tissue-specific way - alongside antioxidant and neuroprotective signaling and pineal/circadian-axis variables.

Cognitive research. Studied for learning, memory, and cognitive-function endpoints in models.

Neuroprotection research. Examined for protection of neural tissue against oxidative and ischemic stress in study models.

Circadian / pineal research. Investigated for pineal-axis and sleep-regulation variables.

How it compares. Pinealon is neuro/cognitive-focused, distinguishing it from telomere-focused Epithalon and the organ-support bioregulators Ovagen and Vesugen.

Research pairings. Studied alongside other Khavinson bioregulators such as Epithalon in longevity-oriented research designs.

Reference research values. Research references commonly cite 1-3 mg daily in short cognitive/longevity-oriented study cycles. Reference values only - not for human or animal use.

Full Pinealon research profile → · Cognitive & Neurological peptides

GHRP-6 (Growth Hormone Releasing Peptide-6) research

GHRP-6 is a hexapeptide and one of the original growth-hormone-releasing peptides. In research it is notable for a strong reported effect on appetite signaling (via ghrelin-receptor activity) in addition to GH release.

Research mechanism. GHRP-6 activates the GH-secretagogue receptor to drive GH pulses and is studied for its pronounced hunger-signaling response, a useful variable in appetite-and-metabolism research.

GH-release research. A potent classic GHRP for growth-hormone-pulse studies.

Appetite-signaling research. Studied where the ghrelin/hunger axis is the variable of interest.

Recovery and tissue models. Examined for downstream recovery endpoints.

How it compares. Compared with Ipamorelin it produces stronger appetite signaling and GH release but with more off-target hormonal activity; GHRP-2 sits between the two.

Research pairings. GHRP-6 is sometimes studied with a GHRH analog like CJC-1295; researchers monitor prolactin in models.

Reference research values. Research references commonly cite 100-300 mcg two to three times daily. Reference values only.

Full GHRP-6 research profile → · Growth Hormone & Muscle peptides

Ovagen (Organ Bioregulator) research

Ovagen is a peptide bioregulator from the Khavinson family, studied for reproductive and organ tissue-support concepts in research models. Peptide bioregulators are investigated for tissue-specific normalization of gene expression and protein synthesis.

Research mechanism. Ovagen research centers on tissue-specific peptide bioregulation - the concept that short peptides can support normal function and protein synthesis in their target organ tissue - within reproductive and organ-support research models.

Reproductive-tissue research. Studied for reproductive and organ tissue-support endpoints in models.

Organ-support research. Examined in bioregulator research focused on tissue normalization concepts.

Longevity bioregulator research. Investigated within the broader Khavinson bioregulator research framework.

How it compares. Ovagen is an organ/reproductive-tissue bioregulator, distinct from the vascular bioregulator Vesugen and the neuro bioregulator Pinealon.

Research pairings. Studied alongside other Khavinson bioregulators (Epithalon, Vesugen, Pinealon) in organ-support research designs.

Reference research values. Research references commonly cite 2-5 mg daily in short-course bioregulator study cycles. Reference values only - not for human or animal use.

Full Ovagen research profile → · Specialty peptides

CJC-1295 (with or without DAC) research

CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH). It is studied in two forms: "no DAC" (also called Mod GRF 1-29), which is short-acting, and "with DAC" (Drug Affinity Complex), which binds albumin for a markedly longer half-life in research models.

Research mechanism. CJC-1295 research focuses on stimulation of the pituitary to release growth hormone in pulses. The DAC version extends the active window, while the no-DAC version produces a sharper, shorter pulse often studied alongside a GHRP such as Ipamorelin for synergistic release.

Growth-hormone release research. The central research theme is endogenous GH-pulse stimulation and the comparison of DAC vs no-DAC kinetics.

Body-composition models. It is studied for downstream effects on muscle and fat metabolism in research models.

GHRH + GHRP synergy studies. CJC-1295 + Ipamorelin is one of the most-studied research pairings for amplified GH pulses.

How it compares. The DAC form trades fewer administrations for a longer, flatter profile; the no-DAC form is studied for sharper, more physiologic pulses. Choice depends on the research kinetics of interest.

Research pairings. CJC-1295 (no DAC) + Ipamorelin is the canonical research pairing; the GHRH analog and the GHRP are reported to act through complementary receptors.

Reference research values. Research references commonly cite 200-300 mcg of the no-DAC form before rest periods on a 5-7 day schedule, or 1-2 mg of the DAC form one to two times weekly. Reference values only.

Full CJC-1295 research profile → · Growth Hormone & Muscle peptides

Tirzepatide (dual GLP-1/GIP agonist) research

Tirzepatide is a dual agonist that activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. It is one of the most-studied modern metabolic research peptides because it engages two incretin pathways at once.

Research mechanism. Tirzepatide research examines combined GLP-1 and GIP signaling on insulin response, satiety, and energy handling, with the dual-pathway mechanism the central research distinction.

Weight-management research. Studied for body-weight endpoints via dual incretin signaling.

Glucose-metabolism research. Examined for combined GLP-1/GIP metabolic effects.

Comparative incretin studies. Frequently compared with semaglutide.

How it compares. Tirzepatide adds GIP activity on top of GLP-1, which is the defining contrast with single-pathway semaglutide in research.

Research pairings. Studied as a standalone dual-agonist model or compared with semaglutide.

Reference research values. Research references describe a titration model from 2.5 mg up to 15 mg weekly over several weeks. Reference values only.

Full Tirzepatide research profile → · Fat Loss & Weight Management peptides

Adamax (Nootropic Peptide Analog) research

Adamax is a synthetic nootropic peptide analog discussed in neuroprotection and cognitive research. It sits in the nootropic-peptide family alongside compounds like Semax and Selank, and is examined for neurotrophic and neuroprotective signaling in research models.

Research mechanism. Adamax research focuses on neurotrophic and neuroprotective signaling - including interest in BDNF-related pathways and neuro-recovery endpoints - as a short-acting nootropic peptide analog.

Cognitive / nootropic research. Studied for attention, memory, and cognitive-performance endpoints in models.

Neuroprotection research. Examined for neuroprotective and neurotrophic signaling.

Neuro-recovery research. Investigated in recovery-oriented neurological research designs.

How it compares. Adamax is a synthetic nootropic analog, distinct from the bioregulator Pinealon and the well-characterized Semax/Selank nootropics, and is treated as a more advanced research compound.

Research pairings. Studied alongside other nootropic peptides such as Semax and Selank in cognitive-research designs.

Reference research values. Research references commonly cite 250-1000 mcg daily depending on the cognitive-research objective, often in an intranasal model. Reference values only - not for human or animal use.

Full Adamax research profile → · Cognitive & Neurological peptides

Research applications studied in Las Cruces

• Potent GH-release research (Hexarelin). Studied where maximal GH-pulse stimulation is the variable.
• Advanced cognitive research (N-Acetyl Semax Amidate). Studied for focus, learning, and mental-clarity endpoints with a longer duration.
• Vascular / endothelial research (Vesugen). Studied for endothelial-function and vessel-support endpoints in models.
• Gut inflammation models (KPV). KPV is studied in models relevant to inflammatory bowel research (such as colitis and Crohn-type models) where epithelial inflammation is the variable.
• Anxiolytic research (Selank). Studied for anxiety endpoints without sedation in models.

How Las Cruces researchers order and store material

Place a one-time or recurring research order through the Peptides Factory Direct portal; checkout requires confirming you are 21 or older and buying for laboratory research only. Material ships to Las Cruces as a stable lyophilized powder; refrigerate on arrival, reconstitute with bacteriostatic water when ready, and keep refrigerated through the research window. Products are research-use-only and not for human or animal consumption, and Las Cruces researchers are responsible for compliance with applicable law. Open the order portal.

Why Las Cruces researchers choose Peptides Factory Direct

What sets Peptides Factory Direct apart for Las Cruces researchers is documentation, not claims. Each Las Cruces order is third-party tested to a 99%+ purity target, ships with lot tracking and a COA on request, and arrives quickly by domestic carrier. The same catalog, purity standard, and research-use terms apply whether material ships to Las Cruces or anywhere else in the US.

Nearby New Mexico research areas we ship to

Frequently asked questions

All New Mexico cities · All states · Research guides

External references: New Mexico (Wikipedia) · U.S. Census Bureau